SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001297184-23-000070
Filing Date
2023-08-16
Accepted
2023-08-16 17:24:20
Documents
18
Period of Report
2023-06-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A amph-20230630x8ka.htm   iXBRL 8-K/A 63005
2 EX-23.1 amph-20230630xex23d1.htm EX-23.1 11737
3 EX-99.1 amph-20230630xex99d1.htm EX-99.1 135430
4 EX-99.2 amph-20230630xex99d2.htm EX-99.2 79522
5 EX-99.3 amph-20230630xex99d3.htm EX-99.3 804126
6 GRAPHIC amph-20230630xex99d1001.jpg GRAPHIC 699
7 GRAPHIC amph-20230630xex99d2001.jpg GRAPHIC 699
  Complete submission text file 0001297184-23-000070.txt   1282259

Data Files

Seq Description Document Type Size
8 EX-101.SCH amph-20230630.xsd EX-101.SCH 3363
9 EX-101.LAB amph-20230630_lab.xml EX-101.LAB 15361
10 EX-101.PRE amph-20230630_pre.xml EX-101.PRE 10385
12 EXTRACTED XBRL INSTANCE DOCUMENT amph-20230630x8ka_htm.xml XML 4683
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36509 | Film No.: 231179130
SIC: 2834 Pharmaceutical Preparations